---
title: "Nature Communications都在用的纯生信泛癌lncRNA发文技术路线分享"
date: 2024-05-26T02:00:08Z
draft: ["false"]
tags: [
  "fetched",
  "生信人"
]
categories: ["Acdemic"]
---
Nature Communications都在用的纯生信泛癌lncRNA发文技术路线分享 by 生信人
------
<div><p><img data-galleryid="" data-imgfileid="503745034" data-ratio="0.3274582560296846" data-src="https://mmbiz.qpic.cn/mmbiz_gif/N3X4LBoaQjU9abk37Q6pRd9QUqmbgwBYMLh9SImibmH2QJhYav5XWHhgxw9GuyLIXqOmyasZ5njzHdvEreJazxg/640?wx_fmt=gif&amp;from=appmsg" data-type="gif" data-w="1078" src="https://mmbiz.qpic.cn/mmbiz_gif/N3X4LBoaQjU9abk37Q6pRd9QUqmbgwBYMLh9SImibmH2QJhYav5XWHhgxw9GuyLIXqOmyasZ5njzHdvEreJazxg/640?wx_fmt=gif&amp;from=appmsg"></p><p><span>小编最近关注到今年<span><strong><span>3</span>月</strong></span>刚刚发表在<span><strong><span>Communications Biology( IF:5.9/Q1)</span></strong></span>杂志上一篇识别<span>TCGA</span>泛癌免疫检查点<span>(ICP)</span>相关<span>lncRNA</span>的纯生信文章，看到后不禁陷入了思考。都<span>2024</span>年了，公共数据的纯生信<span>TCGA</span>泛癌挖掘<span>lncRNA</span>为何还能发一区的近<span>6</span>分杂志呢？带着这样的疑惑小编仔细阅读了文章，</span><span>结果发现该文章使用了一个连<span>Nature Communications</span>都在用的<span>lncRNA</span>分析方法：偏相关分析。</span><span>偏相关分析<span>(Partial Correlations Analysis)</span>也称净相关分析，是指当两个变量同时与第三个变量相关时，将第三个变量的影响剔除，只分析将要探索的两变量间相关程度的过程。</span><br></p><p><br></p><p><span><span>小编查阅文献也发现近两年多篇质量不错的泛癌层面识别热点相关</span><span>lncRNA</span><span>的文章都是使用该方法进行</span><span>lncRNA</span><span>挖掘。不过</span></span><span>统计方法只是研究手段，研究中更重要的是思维，课题开展的关键是因果推断是否合理。</span><span><span>因此小编通过整理相关文章为大家总结了适用该方法的泛癌</span><span>lncRNA</span><span>发文思路：</span></span><span>首先选择一个关注点，选择热点的话会很加分呦；接着使用偏相关分析识别泛癌中该热点相关的lncRNA；最后就是对识别的热点lncRNA进行多角度刻画。</span><span><span>接下来小编通过</span><span>3</span><span>篇典型文章带大家了解该分析思路。</span><p></p></span></p><p><span><strong><span><br></span></strong></span></p><p><span><strong><span>文章一</span></strong><span><span>：该文章就是上面提到的今年</span><span><strong><span>3</span><span>月</span></strong></span><span>发表在</span><span><strong><span>Communications Biology</span></strong></span><span>杂志上识别</span><span>TCGA</span><span>泛癌免疫检查点相关</span><span>lncRNA</span><span>的文章。文章内容丰富，逻辑清晰，值得一提的是结果的可视化也比较好。文章主要内容如下：</span></span><span><p></p></span></span></p><p><strong><span><span>The landscape of immune checkpointrelated long non-coding RNAs core</span><span> </span><span>regulatory circuitry reveals implications</span><span> </span><span>for immunoregulation and immunotherapy</span><span> </span><span>responses</span><span><p></p></span></span></strong></p><p><span><strong><span><span>免疫检查点相关的长链非编码</span><span>RNA</span><span>核心调控回路图谱揭示免疫调节和免疫治疗反应</span></span></strong></span><strong><span></span></strong><br></p><p><span><br></span></p><p><span><span>文章的主要流程如图</span><span>1</span><span>所示。该研究通过</span></span><span>识别泛癌中ICP相关lncRNA，分析了ICP、lncRNA和免疫基因间的调控关系。</span><span><span>接着识别了免疫调节中发挥核心作用的关键</span><span>ICP</span><span>相关</span><span>lncRNA</span><span>。此外，研究也根据</span><span>ICP</span><span>相关</span><span>lncRNA</span><span>对癌症进行分型。研究也分析并验证了</span><span>ICP</span><span>相关</span><span>lncRNA</span><span>对预后和免疫治疗应答的预测效能。</span></span></p><p><img data-galleryid="" data-imgfileid="503746220" data-ratio="0.9074074074074074" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVR0yG2icxy4FnktIuwVsgx4pFxjmN6Iq0lt8dVeHBVy9Ljn0cvBmrbFJ0fMXicr3IP67e4xCtAIUfQ/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVR0yG2icxy4FnktIuwVsgx4pFxjmN6Iq0lt8dVeHBVy9Ljn0cvBmrbFJ0fMXicr3IP67e4xCtAIUfQ/640?wx_fmt=png&amp;from=appmsg"><span>图</span><span>1 ICP</span><span>相关</span><span>lncRNA</span><span>的识别流程</span></p><p><span><strong><span>文章二</span></strong><span><span>：该文章是发表在</span><span><strong><span>BMC Medicine(9.3/Q1)</span></strong></span><span>杂志上利用</span><span>TCGA</span><span>泛癌队列识别糖酵解相关</span><span>lncRNA</span><span>的纯生信文章。文章聚焦糖酵解相关</span><span>lncRNA</span><span>，逻辑清晰，很具有代表性，其主要内容如下：</span><p></p></span></span></p><p><strong><span>Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment<p></p></span></strong></p><p><strong><span><span>基于</span><span><span>糖酵解相关</span>lnc</span><span><span>RNA</span><span>识别</span>预后不良和高浸润性免疫微环境的癌症亚型</span></span></strong><span><strong><span></span></strong><strong><span><p></p></span></strong></span></p><p><span><br></span></p><p><span><span>文章的主要流程如图</span><span>2</span><span>所示，文章</span></span><span>基于TCGA泛癌症队列利用偏相关分析识别了糖酵解相关的lncRNA，并基于这些lncRNA对患者进行分型分析。</span><span><span>研究进一步分析了不同亚型间患者的基因组、转录组、表观组及临床结局等的差异。此外，研究也分析了关键的糖酵解相关</span><span>lncRNA</span><span>与免疫微环境的关联及参与调控的功能。</span><p></p></span></p><p><img data-galleryid="" data-imgfileid="503746221" data-ratio="0.7333333333333333" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVR0yG2icxy4FnktIuwVsgx4iakBH83CuyksSV7ml6yapwDhuGXZuvzkrsQTSogagh3L3AlCoF2yTmQ/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVR0yG2icxy4FnktIuwVsgx4iakBH83CuyksSV7ml6yapwDhuGXZuvzkrsQTSogagh3L3AlCoF2yTmQ/640?wx_fmt=png&amp;from=appmsg"></p><p> <span><span>图</span><span>2 </span><span>泛癌糖酵解相关</span><span>lncRNA</span><span>的识别及分析流程</span></span></p><p><span><strong><span>文章三</span></strong><span><span>：其实和这两篇文章类似的，早在</span><span><strong><span>2020</span><span>年</span><span>Nature communications(16.6/Q1)</span></strong></span><span>就发表过一篇使用偏相关识别泛癌免疫相关</span><span>lncRNA</span><span>的文章。文章的主要内容如下：</span><p></p></span></span></p><p><span><strong><span>Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers<p></p></span></strong></span></p><p><span><strong><span><span>基于泛癌</span><span><span>免疫相关</span>lncRNA</span><span>的特征识别潜在的致癌生物标志物</span></span></strong></span><span><strong><span></span></strong><strong><span><p></p></span></strong></span></p><p><span><br></span></p><p><span><span>文章的主要流程如图</span><span>3</span><span>所示，</span></span><span>研究识别了33种癌症中免疫相关的lncRNA。</span><span><span>研究也分析了免疫相关</span><span>lncRNA</span><span>与免疫细胞浸润的关联。此外，研究也基于免疫相关</span><span>lncRNA</span><span>对癌症样本进行分型，并进一步分析了这些亚型间突变负荷、免疫细胞浸润、免疫调节基因表达、治疗应答及预后差异。</span></span></p><p><img data-galleryid="" data-imgfileid="503746222" data-ratio="0.6611111111111111" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVR0yG2icxy4FnktIuwVsgx4hFkIPq4XFXOJLaR5DjFomgLFRXG62WFibgxgsg2qCowAZy3xDJvysLA/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVR0yG2icxy4FnktIuwVsgx4hFkIPq4XFXOJLaR5DjFomgLFRXG62WFibgxgsg2qCowAZy3xDJvysLA/640?wx_fmt=png&amp;from=appmsg"><span>图</span><span>3 </span><span>识别免疫相关</span><span>lncRNA</span><span>的流程</span></p><p><span><span><span>我们可以看到今天分享的这三个文章都关注了泛癌</span><span>lncRNA</span><span>，只不过选择的关注点有所区别，</span><span>20</span><span>年时的热点是肿瘤免疫，接着第二篇文章则关注了当时大火的糖酵解。进一步随着免疫治疗的发展，今年免疫检查点相关</span><span>lncRNA</span><span>的纯生信分析也同样发了近</span><span>6</span><span>分。将这三篇文章整合起来一个潜力巨大的受到</span><span><strong><span>nature communications</span></strong></span><span>认可的发文思路也就呼之欲出了。</span></span><span><p></p></span></span></p><p><span><br></span></p><p><span><span>其实时隔四年仍有这一系列泛癌</span><span>lncRNA</span><span>挖掘文章的出现也提示我们：</span></span><span>目前识别热点相关的lncRNA，并对识别的lncRNA进行多角度刻画，仍然是一个稳定的5+泛癌纯生信发文思路，毕竟热点年年有。</span><span><p></p></span></p><section data-role="paragraph"><p><br></p></section><section data-tools="135编辑器" data-id="125617" data-color="#00259f"><section><section><section><section data-role="paragraph"><p><span><strong>更多个性化方案设计</strong></span></p><p><span><strong>扫码领取</strong></span></p><p><img data-imgfileid="503746218" data-ratio="1" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVR0yG2icxy4FnktIuwVsgx4sUBxNibDeWrMTbtNcjVamx9894RWDQ2IgXjKEVA5NUVFzxGs9FkYoFQ/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="512" data-width="150px" width="150" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVR0yG2icxy4FnktIuwVsgx4sUBxNibDeWrMTbtNcjVamx9894RWDQ2IgXjKEVA5NUVFzxGs9FkYoFQ/640?wx_fmt=png&amp;from=appmsg"></p><p><strong>适合临床医生的科研方案</strong></p></section><section data-role="paragraph"><p><br></p></section></section></section></section></section><section data-role="paragraph"><p><br></p><section data-tools="135编辑器" data-id="136209" data-color="#00259f"><section><section><section><section><section><section><br></section><section><br></section></section><section><section><br></section><section><br></section></section></section><section><strong>最新文章汇总</strong><span>（持续更新ing）</span></section></section><section data-width="100%"><br></section></section><section><section><section><section><br></section></section><section data-width="100%"><section><span><strong data-brushtype="text"><strong><span>最新热点方向</span></strong></strong></span></section></section></section><section><section data-autoskip="1"><p><span>1、<a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651229281&amp;idx=2&amp;sn=7f80405e8d2b40aa69f2658e9da9183d&amp;chksm=8b5f8b0ebc28021849b172672cd4fc89309f4997537ad283f9a47dff119e2af19c3c4f2e4f92&amp;scene=21#wechat_redirect" textvalue="今天开心，安利一个超好发版干湿结合思路" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2">今天开心，安利一个超好发版干湿结合思路</a></span></p><p><span>2、</span><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651229282&amp;idx=4&amp;sn=60bbb2c5ae38b362ff1a7e5a8e80bf3c&amp;chksm=8b5f8b0dbc28021bb15e7b948b1ec5d06a2c60388b00fd50368948e8d0ce5ffca2335ab75ff8&amp;scene=21#wechat_redirect" textvalue="掌握孟德尔随机化发20分不是梦" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2">掌握孟德尔随机化发20分不是梦</a></p><p><span>3、</span><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651229280&amp;idx=1&amp;sn=eca04f7905098b44749e53c5cebe0076&amp;chksm=8b5f8b0fbc280219f1ebcdde8ce58d0993965baaf01d05461882d08bbf07ae2eef8242d1f242&amp;scene=21#wechat_redirect" textvalue="研究中草药难发SCI？" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2">研究中草药难发SCI？</a></p><p><span>4、</span><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651229264&amp;idx=6&amp;sn=fe295c172ae11bff98867fb5e83264aa&amp;chksm=8b5f8b3fbc2802290a72d4c5d3bfe2c82e7d53d90c781b42cc0c02ea3c8acecc2de2e6b6551d&amp;scene=21#wechat_redirect" textvalue="公开数据纯分析发7+，内容不卷赢在选题" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2">公开数据纯分析发7+，内容不卷赢在选题</a></p><p><span>5、</span><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651229264&amp;idx=2&amp;sn=9154686fece39cb6a3d1072a06aac041&amp;chksm=8b5f8b3fbc280229fba49f3ef98e79ec84a770d14fdd2ac716c5ffd6077fab6bf5d6a8456ae5&amp;scene=21#wechat_redirect" textvalue="人手一篇的“淋巴转移”，摇身一变50+" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2">人手一篇的“淋巴转移”，摇身一变50+</a></p></section></section></section><section><section><section><section><br></section></section><section data-width="100%"><section><span><strong data-brushtype="text"><strong><span>生信人课堂</span></strong></strong></span></section></section></section><section><section data-autoskip="1"><p><span>1、</span><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651228970&amp;idx=7&amp;sn=1310dc5fcd181d48020b801f55e97863&amp;chksm=8b5f8c45bc28055319cd1bbd3a400fdc4385d4ad469f62b530356a24c711b44a61a4cfd918c0&amp;scene=21#wechat_redirect" textvalue="临床医生科研规划" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2">临床医生科研规划</a></p><p><span>2、</span><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651229044&amp;idx=3&amp;sn=91fc8d9347393a7bfce9c1a030728334&amp;chksm=8b5f8c1bbc28050da00f8ed43168999dd8791d13e699641cd4d75c23a2a809db0c98bb2bc5f3&amp;scene=21#wechat_redirect" textvalue="热点基因集预后实操课程" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2">热点基因集预后实操课程</a></p><p><span>3、</span><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651229206&amp;idx=3&amp;sn=d2900b86cd4bc6f452702b444fc278ae&amp;chksm=8b5f8b79bc28026faed6a6ed29566641aca7fc8fe4c6291bfe41901ec49dfc362939886ca6a0&amp;scene=21#wechat_redirect" textvalue="孟德尔随机与基因组" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2">孟德尔随机与基因组</a></p><p><span>4、</span><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651215654&amp;idx=3&amp;sn=02efc087cdc07e2da0526468a21bac9d&amp;chksm=8b5f5049bc28d95f77b9d128be607bfc76884483247f5f844827965f0b416aaa44fd6ef56533&amp;scene=21#wechat_redirect" textvalue="R语言入门" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2">R语言入门</a></p><p><br></p><p><a href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651228874&amp;idx=6&amp;sn=e2c9030b187c654d7faf43f9ae16fa0e&amp;chksm=8b5f8da5bc2804b3a02f80ebe48b9d26cc95b395cc6a955b53b0fd97a996653dd4ed4cc37e08&amp;scene=21#wechat_redirect" data-linktype="2">课题设计</a><span> | <a href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651223612&amp;idx=6&amp;sn=6c1d6704031c8bf69ecc76742b34518e&amp;chksm=8b5f7153bc28f8456c411f5b04b012c4596c2d39e3719a2c9fdd554e8adbe734fb552106fafb&amp;scene=21#wechat_redirect" data-linktype="2">生信分析</a> | <a href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651228415&amp;idx=2&amp;sn=2c65d74e35632ce52094d25e0d2fcf33&amp;chksm=8b5f8f90bc2806866eb21d5e78bc339cdec20a0a08cff9a8e9bd7829bc0cea9616bccd421f1b&amp;scene=21#wechat_redirect" data-linktype="2">数字产品</a></span></p><p><span>概普生物 让科研丰富</span></p><section data-tools="135编辑器" data-id="125822" data-color="#00259f"><section data-bgw="266" data-ratio="0.8421052631578947"><section data-width="40%"><section><img data-imgfileid="503746217" data-ratio="1" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjVR0yG2icxy4FnktIuwVsgx4npNI4cl6ic489AD5za9aU81sR9rGUpjN7csnc7NqiaVyCph7Axn2Fpvw/640?wx_fmt=jpeg&amp;from=appmsg" data-type="jpeg" data-w="258" data-width="100%" src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjVR0yG2icxy4FnktIuwVsgx4npNI4cl6ic489AD5za9aU81sR9rGUpjN7csnc7NqiaVyCph7Axn2Fpvw/640?wx_fmt=jpeg&amp;from=appmsg"></section></section><section data-width="60%"><section><section><section><strong data-brushtype="code">生信人</strong></section><section><section><br></section></section></section></section><section>专注于基因技术相关知识分享</section><section>扫码关注 获取更多</section></section></section></section><p><br></p><p><br></p><section data-tools="135编辑器" data-id="118316" data-color="#00259f"><section><section><section><p><br></p><section><br></section><p><br></p></section><section><strong data-brushtype="text">END</strong></section><section><section><br></section></section></section></section></section><p><br></p></section></section></section></section></section></section><p><br></p><p><mp-style-type data-value="3"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/fzc7ypYOq6XWCmYQQ-vxug",target="_blank" rel="noopener noreferrer">原文链接</a>
